We are live on
!
Find out more
HFCIV
H&F Corporate Investors VIII Portfolio holdings
AUM
$133M
1-Year Est. Return
24.42%
This Fund
S&P 500
This Quarter
Est. Return
+93.46%
1 Year Est. Return
-24.42%
3 Year Est. Return
-33.78%
5 Year Est. Return
-50.35%
10 Year Est. Return
–
AUM
$79.6M
AUM Growth
+$38.5M
(+93%)
Cap. Flow
-$35
Cap. Flow
% of AUM
-0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTEV
Claritev Corp
CTEV
|
+$35 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
NCTC
CWM
FFP
SI
DG
RHIG
VCM
DFG
H&F Corporate Investors VIII's Q4 2024 Portfolio in Review
As of Q4 2024, H&F Corporate Investors VIII held 1 position worth $79.6M, up 93% from $41.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 0%. H&F Corporate Investors VIII opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- H&F Corporate Investors VIII's biggest Q4 2024 reduction was Claritev Corp, cutting an estimated $35.
- H&F Corporate Investors VIII's ten largest holdings make up 100% of its $79.6M portfolio in Q4 2024.
- H&F Corporate Investors VIII opened 0 new positions and closed 0 in Q4 2024.
- H&F Corporate Investors VIII's portfolio value rose 93% quarter-over-quarter to $79.6M.
Based on H&F Corporate Investors VIII's 13F filing for Q4 2024, filed 12 Feb 2025.